Zobrazeno 1 - 3
of 3
pro vyhledávání: '"E. A. Litus"'
Publikováno v:
Acta Biomedica Scientifica, Vol 7, Iss 5-1, Pp 19-26 (2022)
Background. Human serum albumin (HSA) is a natural buffer of amyloid-β peptide (Aβ), a key factor in the development of Alzheimer’s disease (AD). A promising approach to the AD prevention is to reduce the concentration of free Aβ by targeted sti
Externí odkaz:
https://doaj.org/article/df96741f40be4d22a533aade418b441f
Autor:
E. I. Deryusheva, E. A. Litus
Publikováno v:
Journal Biomed. 18:14-17
Human serum albumin (HSA) is a natural buffer for amyloid в peptide (Аβ), which is a key factor in the development of Alzheimer's disease (AD). An increase in HSA affinity to Аβ can be achieved via HSA saturation with low-molecular-weight ligand
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eab5a8bbeb4b129e9bae7035c53bcca2
https://doi.org/10.33647/2074-5982-18-3-14-17
https://doi.org/10.33647/2074-5982-18-3-14-17
Autor:
V. G. Zaitsev, L. V. Goncharova, E. A. Litus, O. V. Ostrovskij, G. P. Dudchenko, V. E. Verovsky
Publikováno v:
Scopus-Elsevier
The aim of this study was to determine the reference interval of serum cobalt-binding capacity (CoBC) and to estimate the effect of factors unrelated to oxidative modification of serum albumin on this diagnostic marker. A group of healthy volunteers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c218d889d41fdd4fcbb0c1954ad4d21d
https://pubmed.ncbi.nlm.nih.gov/25249533
https://pubmed.ncbi.nlm.nih.gov/25249533